Your session is about to expire
← Back to Search
Behavioral Intervention
Cognitive-Behavioral Therapy for ADHD in College Students (ADHD Trial)
N/A
Recruiting
Led By Mary V. Solanto, Ph.D.
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline brief-a at 6 months
Awards & highlights
ADHD Trial Summary
This trial will help college students with ADHD develop skills to succeed in their studies and avoid negative academic outcomes.
Who is the study for?
This trial is for college students at The City College of New York who have been diagnosed with ADHD, either Inattentive or Combined Subtype. Participants should be in good physical health. It's not open to individuals who are actively suicidal, have certain psychiatric disorders like bipolar disorder or borderline personality disorder, a history of severe childhood trauma, neurological issues, recent drug or alcohol abuse, or any acute psychiatric condition that requires immediate treatment.Check my eligibility
What is being tested?
The study is testing a cognitive-behavioral therapy program designed to help college students with ADHD improve their self-management skills. This includes better time management and planning to enhance academic performance and reduce the likelihood of negative educational outcomes.See study design
What are the potential side effects?
Since this trial involves psychological therapy rather than medication, traditional side effects associated with drugs are not expected. However, participants may experience emotional discomfort discussing personal issues during therapy sessions.
ADHD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline aisrs at six months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline aisrs at six months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from Baseline Adult Investigator Symptom Rating Scale (AISRS) at six months
Change from Baseline Behavior Rating Scale of Executive Function - Adult Version (BRIEF-A) at six months
Change from Baseline Learning and Study Strategies Inventory (LASSI) at six months
ADHD Trial Design
1Treatment groups
Experimental Treatment
Group I: Cognitive Behavioral Therapy delivered in a group formatExperimental Treatment1 Intervention
Participating students will be assessed before and after the 12-week group Cognitive-Behavioral intervention to ascertain their response to the treatment.
Find a Location
Who is running the clinical trial?
Northwell HealthLead Sponsor
460 Previous Clinical Trials
471,001 Total Patients Enrolled
2 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
525 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
The City College of New YorkOTHER
27 Previous Clinical Trials
6,366 Total Patients Enrolled
Mary V. Solanto, Ph.D.Principal InvestigatorNorthwell Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with borderline personality disorder.I have a neurological disorder like a brain injury, tumor, or Parkinson's.I am in good physical health.I have been diagnosed with a psychotic disorder.I do not have a severe mental health condition that needs immediate treatment over ADHD.I have been diagnosed with ADHD, either inattentive or combined type.I have been diagnosed with bipolar disorder.
Research Study Groups:
This trial has the following groups:- Group 1: Cognitive Behavioral Therapy delivered in a group format
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Attention Deficit Hyperactivity Disorder (ADHD) Patient Testimony for trial: Trial Name: NCT05588505 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the age limit for this experiment restricted to those aged 35 or younger?
"According to the requirements for participation in this study, individuals must be between 18 and 30 years old."
Answered by AI
How many participants have been admitted into this clinical trial?
"Indeed, the clinicaltrials.gov website confirms that this medical research has begun seeking participants since September 1st 2022. The latest update was posted on October 24th and they are currently looking for 42 patients from one site."
Answered by AI
Are there any openings for participants to join the trial at this time?
"Indeed, the information hosted on clinicaltrials.gov reveals that this investigation is actively seeking participants. This trial was initially posted in early September of 2022 and has since been revised at the end of October 2022. Forty-two volunteers are required from a single medical site for successful completion of this study."
Answered by AI
Who else is applying?
What state do they live in?
California
Ohio
New York
Other
How old are they?
18 - 65
What site did they apply to?
City College of New York
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
1
0
3+
Why did patients apply to this trial?
I'm looking for a new treatment. Ritalin wellbutrition and manafinidate. I would like to be evaluated for ADHD because I feel it was not properly evaluated when I was younger.
PatientReceived 2+ prior treatments
I am 22, just got accepted in College at Cincinnati State Regionals and I also just recently have gotten diagnosed with ADHD. It is something I have struggled with my whole life and is just now all making sense. I’m learning how to deal with the symptoms and how to be the best me. Anything that is trying to make ADHD easier to control, is something I want to be apart of especially for my academic future!
PatientReceived no prior treatments
What questions have other patients asked about this trial?
Will there be medication involved?
PatientReceived 2+ prior treatments
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger